Detalhe da pesquisa
1.
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.
Vaccines (Basel)
; 11(3)2023 Mar 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36992257
2.
Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models.
NPJ Vaccines
; 8(1): 45, 2023 Mar 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36949051
3.
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models.
Vaccine
; 40(6): 934-944, 2022 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34973849
4.
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
J Exp Med
; 218(7)2021 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33909009
5.
Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice.
NPJ Vaccines
; 5(1): 49, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32566260